Literature DB >> 30858220

Long-Term Low Rate of Macrolide-Resistant Mycoplasma pneumoniae Strains in Germany.

Roger Dumke1, Thomas Ziegler2.   

Abstract

Entities:  

Keywords:  Mycoplasma pneumoniae

Mesh：

Substances：

Year:  2019        PMID： 30858220      PMCID： PMC6496069          DOI： 10.1128/AAC.00455-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

1.  Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011.

Authors:  S A Uldum; J M Bangsborg; B Gahrn-Hansen; R Ljung; M Mølvadgaard; R Føns Petersen; C Wiid Svarrer
Journal:  Euro Surveill       Date:  2012-02-02

2.  Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.

Authors:  R Dumke; H von Baum; P C Lück; E Jacobs
Journal:  Clin Microbiol Infect       Date:  2009-09-17       Impact factor: 8.067

3.  Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia.

Authors:  Roger Dumke; Simone Stolz; Enno Jacobs; Thomas Juretzek
Journal:  Int J Infect Dis       Date:  2014-10-18       Impact factor: 3.623

4.  Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012.

Authors:  Roger Dumke; Christian Lück; Enno Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

5.  Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands.

Authors:  Emiel B M Spuesens; Adam Meijer; Damien Bierschenk; Theo Hoogenboezem; Gé A Donker; Nico G Hartwig; Marion P G Koopmans; Cornelis Vink; Annemarie M C van Rossum
Journal:  J Clin Microbiol       Date:  2012-04-11       Impact factor: 5.948

6.  European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009).

Authors:  Niels Adriaenssens; Samuel Coenen; Ann Versporten; Arno Muller; Girma Minalu; Christel Faes; Vanessa Vankerckhoven; Marc Aerts; Niel Hens; Geert Molenberghs; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2011-12       Impact factor: 5.790

7.  Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012.

Authors:  Roger Dumke; Christiane Schnee; Mathias W Pletz; Jan Rupp; Enno Jacobs; Konrad Sachse; Gernot Rohde
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

8.  Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.

Authors:  Takaaki Tanaka; Tomohiro Oishi; Ippei Miyata; Shoko Wakabayashi; Mina Kono; Sahoko Ono; Atsushi Kato; Yoko Fukuda; Aki Saito; Eisuke Kondo; Hideto Teranishi; Yuhei Tanaka; Tokio Wakabayashi; Hiroto Akaike; Satoko Ogita; Naoki Ohno; Takashi Nakano; Kihei Terada; Kazunobu Ouchi
Journal:  Emerg Infect Dis       Date:  2017-10       Impact factor: 6.883

9.  No detection of macrolide-resistant Mycoplasma pneumoniae from Swedish patients, 1996-2013.

Authors:  Karolina Gullsby; Kåre Bondeson
Journal:  Infect Ecol Epidemiol       Date:  2016-06-01

Review 10.  Mycoplasma pneumoniae: Current Knowledge on Macrolide Resistance and Treatment.

Authors:  Sabine Pereyre; Julien Goret; Cécile Bébéar
Journal:  Front Microbiol       Date:  2016-06-22       Impact factor: 5.640
View more
  3 in total

1.  Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis.

Authors:  Kyunghoon Kim; Sungsu Jung; Mina Kim; Suyeon Park; Hyeon-Jong Yang; Eun Lee
Journal:  JAMA Netw Open       Date:  2022-07-01

2.  Sequence Type Changes Associated with Decreasing Macrolide-Resistant Mycoplasma pneumoniae, Japan.

Authors:  Miyuki Morozumi; Takeshi Tajima; Megumi Sakuma; Michi Shouji; Hidenori Meguro; Kota Saito; Satoshi Iwata; Kimiko Ubukata
Journal:  Emerg Infect Dis       Date:  2020-09       Impact factor: 6.883

3.  Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials.

Authors:  Susanne Paukner; David Mariano; Anita F Das; Gregory J Moran; Christian Sandrock; Ken B Waites; Thomas M File
Journal:  Antibiotics (Basel)       Date:  2021-12-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.